Comparison of gefitinib versus erlotinib in patients with nonsmall cell lung cancer who failed previous chemotherapy
… that gefitinib and erlotinib appeared to have similar outcomes in patients with advanced/…
chemotherapy. The overall response rates and disease control rates in the gefitinib- and erlotinib…
chemotherapy. The overall response rates and disease control rates in the gefitinib- and erlotinib…
Randomized phase II study of gefitinib versus erlotinib in patients with advanced non-small cell lung cancer who failed previous chemotherapy
… to be the sequela of previous platinum-based chemotherapy. … II trial of erlotinib or standard
chemotherapy in patients with … for patients who developed moderate to severe skin rash on …
chemotherapy in patients with … for patients who developed moderate to severe skin rash on …
High efficacy of erlotinib in Taiwanese NSCLC patients in an expanded access program study previously treated with chemotherapy
RP Perng, CH Yang, YM Chen, GC Chang, MC Lin… - Lung Cancer, 2008 - Elsevier
… (EGFR) pathway with tyrosine kinase inhibitor (TKI) is an effective and promising salvage
treatment for NSCLC patients who have failed previous chemotherapy, especially for Asian …
treatment for NSCLC patients who have failed previous chemotherapy, especially for Asian …
Chemotherapy with erlotinib or chemotherapy alone in advanced non‐small cell lung cancer with acquired resistance to EGFR tyrosine kinase inhibitors
SB Goldberg, GR Oxnard, S Digumarthy… - The …, 2013 - academic.oup.com
… chemotherapy alone after the development of TKI resistance. We found that continuing
erlotinib with chemotherapy … a reasonable treatment option for patients with EGFR‐mutant lung …
erlotinib with chemotherapy … a reasonable treatment option for patients with EGFR‐mutant lung …
A phase II pharmacodynamic study of erlotinib in patients with advanced non–small cell lung cancer previously treated with platinum-based chemotherapy
E Felip, F Rojo, M Reck, A Heller, B Klughammer… - Clinical Cancer …, 2008 - AACR
… In summary, the findings of this study concur with those of previous research and suggest …
for clinical benefit with erlotinib in patients with NSCLC. Erlotinib suppressed EGFR-mediated …
for clinical benefit with erlotinib in patients with NSCLC. Erlotinib suppressed EGFR-mediated …
[HTML][HTML] Erlotinib in previously treated non–small-cell lung cancer
FA Shepherd, J Rodrigues Pereira… - New England journal …, 2005 - Mass Medical Soc
… The patients had to have received one or two regimens of combination chemotherapy and
not be eligible for further chemotherapy. Patients 70 years of age or older may have received …
not be eligible for further chemotherapy. Patients 70 years of age or older may have received …
Chemotherapy plus erlotinib versus chemotherapy alone for treating advanced non-small cell lung cancer: a meta-analysis
JL Xu, B Jin, ZH Ren, YQ Lou, ZR Zhou, QZ Yang… - PloS one, 2015 - journals.plos.org
… In this meta-analysis, continuous erlotinib plus chemotherapy versus chemotherapy alone
failed to show improvements in PFS and OS. A previous systematic review demonstrated that …
failed to show improvements in PFS and OS. A previous systematic review demonstrated that …
Clinical efficacy of erlotinib in patients previously treated for advanced non‐small cell lung cancer
S Zhou, S Ren, L Yan, L Zhang, L Tang, J Zhang… - …, 2009 - Wiley Online Library
… patients received erlotinib at a fixed oral dose of 150 mg daily and concomitant use of
chemotherapeutic … stage, previous treatments and smoking status was performed on the 108 …
chemotherapeutic … stage, previous treatments and smoking status was performed on the 108 …
Randomized, placebo-controlled, phase II study of sequential erlotinib and chemotherapy as first-line treatment for advanced non–small-cell lung cancer
… combination of chemotherapy with erlotinib, followed by erlotinib maintenance therapy. …
administration of erlotinib with chemotherapy has demonstrated promising results in patients with …
administration of erlotinib with chemotherapy has demonstrated promising results in patients with …
Approval summary for erlotinib for treatment of patients with locally advanced or metastatic non–small cell lung cancer after failure of at least one prior chemotherapy …
JR Johnson, M Cohen, R Sridhara, YF Chen… - Clinical Cancer …, 2005 - AACR
… EGFR status measured by immunohistochemistry was not a predictor of tumor response in
previous lung cancer clinical trials with erlotinib or gefitinib, a related EGFR tyrosine kinase …
previous lung cancer clinical trials with erlotinib or gefitinib, a related EGFR tyrosine kinase …
相关搜索
- erlotinib in patients cell lung cancer
- second line erlotinib in patients
- erlotinib for patients egfr expression
- erlotinib in patients adverse events
- erlotinib in patients tumor response
- erlotinib in japanese patients
- standard chemotherapy in patients
- acquired resistance chemotherapy with erlotinib
- erlotinib in previously treated patients
- prior chemotherapy regimen erlotinib for treatment
- erlotinib and gefitinib taiwanese patients
- paclitaxel chemotherapy erlotinib hydrochloride
- efficacy of erlotinib conventional chemotherapy
- previous chemotherapy comparison of gefitinib
- previous chemotherapy randomized phase ii study
- erlotinib in patients phase 3b trial